When action movie star Chuck Norris earlier this month filed suit against firms involved in the distribution of gadolinium-based contrast agents, he put a human face on the gadolinium retention issue. MRI safety expert Dr. Emanuel Kanal of the University of Pittsburgh discusses the latest findings in what's known about gadolinium safety in this video.
Correction, Kanal Video 1 My MistakeVideo from RSNA 2017: Gadolinium retention debate takes center stage
Nov 28, 2017
Latest in Home
Using GPT‑4o with CT exams helps diagnose ovarian cancer earlier
February 18, 2026
Survey: Nearly 4 out of 5 practices short on breast imagers
February 18, 2026
Cardiac MRI-based ML model predicts MACE risk for STEMI patients
February 17, 2026


















